OAKGROVE BIO LLC

WILMINGTON, DE · Biotech · Private

Recombinant microbial cell factories for low-cost peptide synthesis and purification

Grants
$1.3M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I:Cost-Effective Peptide Production Platform$256,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Cost-Effective Peptide Production Platform$1,000,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1312TING THERAPEUTICS LLC——
1313Kodikaz Therapeutic Solutions, Inc.——
1314THERATARGET, INC.——
1315OAKGROVE BIO LLC——
1316MEDVAS CONCEPTS, LLC——
1317CADRE BIOSCIENCE, LLC——
1318BOTANISOL, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 3
  • Biological Production of Histidine-Rich Peptidesapplication
  • Biological Production Of Histidine-rich Peptidesapplication
  • Biological Production Of Histidine-rich Peptidesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.